14.23
Oruka Therapeutics Inc Aktie (ORKA) Neueste Nachrichten
What drives Oruka Therapeutics Inc. stock priceOverwhelming financial success - Autocar Professional
Is Oruka Therapeutics Inc. a good long term investmentAccelerated investment success - Autocar Professional
H.C. Wainwright reiterates Buy rating on Oruka Therapeutics stock as FDA clears IND - Investing.com Canada
Oruka Therapeutics Shares Climb After FDA Greenlights Psoriasis Drug Trial - MSN
Oruka Therapeutics Inc. Stock Analysis and ForecastMassive profits - Autocar Professional
What analysts say about Oruka Therapeutics Inc. stockExponential return rates - jammulinksnews.com
Wedbush Reiterates Outperform Rating for Oruka Therapeutics (NASDAQ:ORKA) - Defense World
Oruka Therapeutics Announces IND Clearance for EVERLAST-A - GlobeNewswire
Oruka Therapeutics stock rises after FDA clears IND for psoriasis drug - Investing.com India
Stifel reiterates Buy rating on Oruka Therapeutics stock with $47 target - Investing.com Canada
Oruka Therapeutics: Revolutionizing Psoriasis Treatment with Extended-Dosing Biologics - AInvest
FDA clears Oruka’s IND for psoriasis drug ORKA-001 phase 2a trial - Investing.com India
Oruka Therapeutics Announces IND Clearance for EVERLAST-A Phase 2a Trial of ORKA-001 in Psoriasis with Phase 1 Data to be Presented at EADV in September - Yahoo Finance
How high can Oruka Therapeutics Inc. stock price go in 2025Balanced Risk Reward Portfolio - Newser
How Oruka Therapeutics Inc. stock performs during market volatilityDaily Volume Leaders - Newser
Why Oruka Therapeutics Inc. stock attracts strong analyst attentionFree Real-Time Stock Data - Newser
What makes Oruka Therapeutics Inc. stock price move sharplyWeekly Big Movers - Newser
Oruka Therapeutics, Inc. (NASDAQ:ORKA) Receives Consensus Rating of “Buy” from Analysts - Defense World
Oruka Therapeutics announces COO appointment - MSN
Oruka Therapeutics Shares Soar 16.1% on Executive Promotion, Index Inclusion - AInvest
Oruka Therapeutics Promotes Laura Sandler to COO - MarketScreener
Oruka Therapeutics promotes Laura Sandler to chief operating officer - Investing.com
Oruka Therapeutics Announces Promotion of Laura Sandler to Chief Operating Officer - GlobeNewswire
Oruka Therapeutics Appoints New Chief Operating Officer - TipRanks
Oruka Therapeutics, Inc.(NasdaqGM: ORKA) added to Russell 3000E Index - MarketScreener
Oruka Therapeutics, Inc. (NASDAQ:ORKA) Given Average Recommendation of “Buy” by Analysts - Defense World
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):